Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Prelude Therapeutics (PRLD) Other Gross PP&E Adjustments (2024 - 2025)

Prelude Therapeutics (PRLD) has disclosed Other Gross PP&E Adjustments for 2 consecutive years, with -$36.1 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 12.72% to -$36.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$36.1 million through Dec 2025, down 12.72% year-over-year, with the annual reading at -$36.1 million for FY2025, 12.72% down from the prior year.
  • Other Gross PP&E Adjustments hit -$36.1 million in Q4 2025 for Prelude Therapeutics, down from -$27.5 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$27.5 million in Q3 2025 to a low of -$36.1 million in Q4 2025.